RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
Pediatric Brain Tumor Consortium – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Lymphoma Therapy Area Pipeline Report
Nov 2010 - 233 pages - $1,495
Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 143 pages - $1,495
Follicular Lymphoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 61 pages - $1,000
Non-Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 622 pages - $1,495
Cutaneous T-cell Lymphoma Therapy Area Pipeline Report
Nov 2010 - 101 pages - $1,495
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011
Jan 2011 - 24 pages - $1,000
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Pediatric del
Therapeutic target
Oncology del
Lymphoma del
Development phase
Phase I/II del

Browse By

Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us